Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
eF2abn9vqfHLuUmY
